
Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Illinois, Jan. 19, 2017 – Astellas has been named for the second year one of Corporate Knights’ 2017 Global 100 Most Sustainable Corporations in the World, moving up 10 spots in...
- Complete results of Phase 1/2 CHRYSALIS trial of gilteritinib in patients with Relapsed/Refractory AML to be presented during Oral Session on Dec. 5 - NORTHBROOK, Ill., Nov. 17, 2016 /PRNewswire/ --
Doug Noland will serve as Executive Director NORTHBROOK, Ill., Nov. 2, 2016 /PRNewswire/ -- Astellas today announced the creation of a new department in the Americas that will formally build on...
Read more about Astellas Establishes Patient Experience Organization in the Americas
-Social Shares of #OrganDonor Support $5 Contribution from Astellas to World Transplant Games Federation, up to $175,000 USD- NORTHBROOK, Ill. and RICHMOND, Va., Oct. 27, 2016 /PRNewswire/ -- At...
NORTHBROOK, Ill., Oct. 26, 2016 /PRNewswire/ -- Astellas USA Foundation has named Moyra Knight as president, transitioning from Jeffrey A. Winton, outgoing Astellas USA Foundation president....
Read more about Astellas USA Foundation names Moyra Knight as President